GILD

Gilead Sciences, Inc. News Headlines

$100.58
*  
0.01
0.01%
Get GILD Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Alder Biopharmaceuticals Slumps: ALDR Tanks 13.2% in Session - Tale of the Tape
9/3/2014 7:51:00 AM - Zacks.com


Cramer's Mad Money - Fascinating Schisms (9/2/14)
9/3/2014 6:17:00 AM - Seeking Alpha


Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog
9/2/2014 5:50:00 PM - Zacks.com


AstraZeneca Reports Data on Brilinta from ATLANTIC Study - Analyst Blog
9/2/2014 5:40:00 PM - Zacks.com


Bayer/Johnson & Johnson to Expand Xarelto Label Further - Analyst Blog
9/2/2014 5:30:00 PM - Zacks.com


United Therapeutics Soars on Remodulin Patent Case Win - Analyst Blog
9/2/2014 5:25:00 PM - Zacks.com


Gilead Sciences: Time To Take Profits?
9/2/2014 4:40:00 PM - Seeking Alpha


Novartis Releases Positive Data on LCZ696 for Heart Failure - Analyst Blog
9/2/2014 4:10:00 PM - Zacks.com


Prestige Brands to Sell Bonine for Insight Acquisition - Analyst Blog
9/2/2014 3:35:00 PM - Zacks.com


BioCryst's Ebola Candidate Moving to Efficacy Study Soon - Analyst Blog
9/2/2014 2:08:00 PM - Zacks.com


Gilead Sciences Is Not Done Running
9/2/2014 10:04:00 AM - Seeking Alpha


Biotechnology, Oil And Brazil ETFs To Watch This Week
9/2/2014 9:05:59 AM - Benzinga


Ambit Biosciences (AMBI) Jumps: Stock Up 6.6% - Tale of the Tape
9/2/2014 8:04:00 AM - Zacks.com


PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 03, 2014
9/2/2014 8:00:01 AM - NASDAQ.com News


3 Simple Ways to Invest Like George Soros
8/30/2014 10:42:02 AM - Motley Fool


Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
8/29/2014 5:30:00 PM - Zacks.com


Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
8/29/2014 5:10:00 PM - Zacks.com


Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog
8/29/2014 4:10:00 PM - Zacks.com


Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog
8/29/2014 4:00:00 PM - Zacks.com


Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
8/29/2014 3:55:00 PM - Zacks.com


Momenta-Sandoz's Generic Copaxone Accepted for Review by FDA - Analyst Blog
8/29/2014 2:20:00 PM - Zacks.com


Market Posts Best August In 14 Years. Why Don't Investors Feel Better?
8/29/2014 10:30:00 AM - Seeking Alpha


Today's Market: Red Hot Biotech And Big Pharma Names To Watch
8/29/2014 8:22:00 AM - Seeking Alpha


Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape
8/29/2014 8:11:00 AM - Zacks.com


Why Gilead Sciences (GILD) Could Be Positioned for a Surge? - Tale of the Tape
8/29/2014 7:53:00 AM - Zacks.com